Life Sciences
A lung pathogen's dilemma: infect or resist antibiotics?
Research
EPFL
A new study by EPFL reveals that the notorious bacterial pathogen Pseudomonas aeruginosa must balance between effectively colonizing human airways and developing antibiotic tolerance to survive.
Unexpected immune response may hold key to long-term cancer remission
Research
EPFL
Results from a preclinical study in mice, led by EPFL, and a collaborative clinical study in patients show that the type 2 immune response – associated with parasitic infection and thought to play a negative role in cancer immunity – is positively correlated with long-term cancer remission.
Medical imaging aims to bring the invisible to light
Research
EPFL
Medical imaging technology – such as MRI, ultrasound and X-ray – is gaining in power and precision, especially in the wake of recent breakthroughs in artificial intelligence. Several EPFL research groups are contributing to this progress and actively shaping the future in this area.
How epigenetics influence memory formation
Research
EPFL
In an important study for understanding how memories are made, EPFL scientists show that the flexibility of chromatin – packaged DNA inside the cell – plays a crucial role in “deciding” which neurons are involved in forming a specific memory.
Enhancing breast cancer diagnosis and treatment
Research
EPFL
Addressing problems with diagnosing and treating breast cancer, scientists at EPFL have developed EMBER, a tool that integrates breast cancer transcriptomic data from multiple databases. EMBER can improve precision oncology by accurately predicting molecular subtypes and therapy responses.
AI matches protein interaction partners
Research
EPFL
Scientists at EPFL unveil DiffPALM, an innovative AI method that enhances the prediction of protein interactions and our understanding of biological processes potentially relevant to medical applications.
Page 1 of 15